Premium
Pharmacokinetics of nifedipine in Taiwanese
Author(s) -
Chien ShuChen,
Uang YowShieng,
Lin HsiuYi,
Hsu KuangYang
Publication year - 2004
Publication title -
biopharmaceutics and drug disposition
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.419
H-Index - 58
eISSN - 1099-081X
pISSN - 0142-2782
DOI - 10.1002/bdd.386
Subject(s) - nifedipine , pharmacokinetics , pharmacology , medicine , calcium
To elucidate the pharmacokinetics of nifedipine in Taiwanese, a retrospective review of nifedipine bioequivalence studies completed in Taiwan in the past 5 years was conducted. A total of 198 healthy male volunteers were given a single dose of a 10 mg Adalat ® capsule as a reference drug after overnight fasting. Pharmacokinetic parameters derived from Adalat ® administration were calculated by non‐compartmental analysis with the WinNonlin program. After oral administration of an immediate‐release dosage form of a 10 mg nifedipine capsule to Taiwan residents, a skewed distribution with no clear evidence of bimodality of pharmacokinetic parameters was observed. The mean C max was 143.12±53.48 ng/ml, the mean AUC was 293.77±115.62 ng·h/ml, the mean T 1/2 was 3.08±1.61 h, and the median value of T max was 0.61 h. Compared with other published studies, the C max and AUC of nifedipine after 10 mg administration were significantly higher in Taiwanese than in British and American subjects. However, the C max and AUC were similar to those of Indian and Mexican subjects. According to the antimode of AUC distribution of 22.5 ng·h/ml/mg proposed by Kleinbloesem, 69.7% of Taiwanese can be categorized as slow metabolizers. Based on the results in this study, the majority of Taiwanese show lower activity of nifedipine metabolism. Copyright © 2004 John Wiley & Sons, Ltd.